NANOG and neuroblastoma: Most importantly, R+D ‘pre-treatment’ compared to control (vehicle) treatment proficiently reduced the elevated CXCR4, BMI1 and NANOG protein expression in spheroid cultures in both neuroblastoma cell lines (Figure 7b).